As reported by Wang et al. [39], sodium butyrate has the potential to mitigate hypertension induced by angiotensin II and improves the associated renal injury, encompassing urinary albumin excretion, glomerulosclerosis, and renal fibrosis. This evidence concerns the gene AGT and glomerulosclerosis.